Subscribe to RSS

DOI: 10.1055/s-0045-1812301
Prognostic biomarkers in ischemic stroke treated with mechanical thrombectomy: a systematic review
Authors
Abstract
Background
Mechanical thrombectomy (MT) is a key therapy for acute ischemic stroke (AIS), improving survival and functional outcomes. However, the variability in results highlights the need for predictive markers to refine patient selection. Biomarkers reflecting inflammation and metabolic stress are gaining recognition for their role in AIS and MT outcomes.
Objective
To systematically review and synthesize the evidence on biomarkers associated with clinical outcomes in AIS patients undergoing MT. Specific aims include evaluating their relationship with functional recovery (mRS), mortality, infarct volume, hemorrhagic transformation, and complications such as malignant brain edema (MBE) and delayed cerebral ischemia (DCI).
Methods
A systematic review of the literature was conducted in accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement to identify studies evaluating biomarkers in MT. The PubMed and Embase databases were searched using the following terms: (Marker OR biomarker*) AND (Mechanical Thrombectomy OR endovascular) AND Stroke.
Results
Of 2,834 articles identified, 86 met inclusion criteria. Several biomarkers, such as C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), adenosine deaminase (ADA), neuron-specific enolase (NSE), and matrix metalloproteinase-9 (MMP-9), were consistently associated with worse functional outcomes, increased mortality, and higher risk of complications including hemorrhagic transformation and MBE.
Conclusion
Multiple biomarkers demonstrate prognostic value in AIS patients undergoing MT. These findings may support risk stratification and individualized care, though further prospective studies are needed to integrate these biomarkers into the clinical practice.
Data Availability Statement
This study is a systematic review, and all data analyzed were extracted from previously published studies. The datasets supporting the findings of this review are available in the original articles cited in the manuscript. No new data were collected specifically for this study.
Authors' Contributions
Conceptualization: RFR, RCTH, SB, JBL, GPM, PHMO, AN, ASC, LM, MLBM, JCR, PLMM, SMO; Data curation: RFR, RCTH, SB, PHMO, AN, ASC, LM, MLBM, PLMM, SMO; Formal analysis: RFR, RCTH, SB, JBL, GPM, PHMO, AN, ASC, LM, MLBM, PLMM, SMO; Investigation: RFR, SB, SMO; Methodology: RFR, RCTH, SB, JBL, GPM, PHMO, AN, ASC, LM, MLBM, PLMM, SMO; Project administration: RFR, RCTH, SB, SMO; Resources: RFR, SMO; Software: RFR, SB, SMO; Supervision: RFR, RCTH, SB, SMO; Validation: RFR, RCTH, SB, JBL, GPM, MLBM, JCR, PLMM, SMO; Visualization: RFR, RCTH, SB, JBL, GPM, PHMO, AN, ASC, LM, MLBM, JCR, PLMM, SMO; Writing - original draft: RFR, RCTH, SB, JBL, GPM, PHMO, AN, ASC, LM, MLBM, JCR, PLMM, SMO.
Editor-in-Chief: Ayrton Roberto Massaro (ORCID: 0000-0002-0487-5299).
Associate Editor: Octávio Marques Pontes Neto (ORCID: 0000-0003-0317-843X).
Publication History
Received: 06 April 2025
Accepted: 27 July 2025
Article published online:
31 October 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Rodrigo Fellipe Rodrigues, Raquel Cristina Trovo Hidalgo, Savio Batista, Júlia Belone Lopes, Gabriel Paulo Mantovani, Pedro Henrique Matos Oliveira, André Nishizima, Anderson Silva Corin, Lucas Macedo, Mariana Letícia de Bastos Maximiano, Pedro Lucas Machado Magalhães, Julia Camargo Ricci, Sonia Maria Oliani. Prognostic biomarkers in ischemic stroke treated with mechanical thrombectomy: a systematic review. Arq Neuropsiquiatr 2025; 83: s00451812301.
DOI: 10.1055/s-0045-1812301
-
References
- 1 Raha O, Hall C, Malik A, D'Anna L, Lobotesis K, Kwan J, Banerjee S. Advances in mechanical thrombectomy for acute ischaemic stroke. BMJ Med 2023; 2 (01) e000407
- 2 Shen H, Killingsworth MC, Bhaskar SMM. Comprehensive Meta-Analysis of Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: Prevalence, Factors, and Clinical Outcomes. Life (Basel) 2023; 13 (10) 1965
- 3 Wang H, Tian X, Liao Z, Yue X, Sun L, Li X. et al. Inflammatory biomarkers may be associated with poor outcomes after mechanical thrombectomy. Thromb J 2024; 22 (01) 58
- 4 Maas MB, Furie KL. Molecular biomarkers in stroke diagnosis and prognosis. Biomarkers Med 2009; 3 (04) 363-383
- 5 Maglinger B, McLouth CJ, Frank JA, Rupareliya C, Sands M, Sheikhi L. et al. Influence of BMI on adenosine deaminase and stroke outcomes in mechanical thrombectomy subjects. Brain Behav Immun Health 2022; 20: 100422
- 6 Xiao M, Zhao X, Luo J, Zhu Z, Wei L, Li B. et al. High Systemic Inflammatory Protein Index Is Associated with Clinically Ineffective Reperfusion in Acute Anterior Circulation Ischemic Stroke Patients Undergoing Endovascular Treatment. Mol Neurobiol 2024; 61 (10) 7707-7716
- 7 Chen Z, He Y, Su Y, Sun Y, Zhang Y, Chen H. Association of inflammatory and platelet volume markers with clinical outcome in patients with anterior circulation ischaemic stroke after endovascular thrombectomy. Neurol Res 2021; 43 (06) 503-510
- 8 Al-Mufti F, Khandelwal P, Sursal T, Cooper JB, Feldstein E, Amuluru K. et al. Neutrophil-Lymphocyte ratio is associated with poor clinical outcome after mechanical thrombectomy in stroke in patients with COVID-19. Interv Neuroradiol 2023; 29 (04) 386-392
- 9 Bartt R, Sercy E, Pirahanchi Y, Frei Jr D, Bar-Or D. Associations of Neutrophil-Lymphocyte Ratios with Reperfusion and Functional Outcomes in Ischemic Stroke after Endovascular Therapy. J Stroke Cerebrovasc Dis 2022; 31 (12) 106843
- 10 Du M, Xu L, Zhang X, Huang X, Cao H, Qiu F. et al. Association Between Inflammatory Burden Index and Unfavorable Prognosis After Endovascular Thrombectomy in Acute Ischemic Stroke. J Inflamm Res 2023; 16: 3009-3017
- 11 Goyal N, Tsivgoulis G, Chang JJ, Malhotra K, Pandhi A, Ishfaq MF. et al. Admission Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker of Outcomes in Large Vessel Occlusion Strokes. Stroke 2018; 49 (08) 1985-1987
- 12 Liang D, Zeng X, Yao M, Li F, Lin J, Zhang L. et al. Dynamic changes in the glycocalyx and clinical outcomes in patients undergoing endovascular treatments for large vessel occlusion. Front Neurol 2023; 14: 1046915
- 13 Xu B, Yin T, Sun T, Li Z, Zhang Z, Lv H. et al. Peripheral blood syndecan-1 levels after mechanical thrombectomy can predict the clinical prognosis of patients with acute ischemic stroke. Acta Neurochir (Wien) 2024; 166 (01) 153
- 14 Martha SR, Cheng Q, Fraser JF, Gong L, Collier LA, Davis SM. et al. Expression of Cytokines and Chemokines as Predictors of Stroke Outcomes in Acute Ischemic Stroke. Front Neurol 2020; 10: 1391
- 15 Karaszewski B, Gójska-Grymajło A, Czaplewska P, Jabłoński B, Lewandowska AE, Ossowska D. et al. SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study. Sci Rep 2021; 11 (01) 18765
- 16 Xu J, Jiang X, Liu Q, Liu J, Fang J, He L. Lower serum uric acid to serum creatinine ratio as a predictor of poor functional outcome after mechanical thrombectomy in acute ischaemic stroke. Eur J Neurol 2024; 31 (07) e16296
- 17 Yang B, Chen X, Li F, Zhang J, Dong D, Ou H. et al. Stress hyperglycemia increases short-term mortality in acute ischemic stroke patients after mechanical thrombectomy. Diabetol Metab Syndr 2024; 16 (01) 32
- 18 Wang H, Yuan R, Shen P, Yu X, Chen X, Shang Y. et al. Association between Peripheral Arterial Lactate Levels and Malignant Brain Edema Following Endovascular Treatment for Ischemic Stroke. Curr Neurovasc Res 2024; 20 (05) 535-543
- 19 Barba L, Vollmuth C, Abu-Rumeileh S, Halbgebauer S, Oeckl P, Steinacker P. et al. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke. Sci Rep 2023; 13 (01) 20941
- 20 Feng X, Zhang Y, Li Q, Wang B, Shen J. Hemoglobin to red cell distribution width ratio as a prognostic marker for ischemic stroke after mechanical thrombectomy. Front Aging Neurosci 2023; 15: 1259668
- 21 Jabrah D, Rossi R, Molina S, Douglas A, Pandit A, McCarthy R. et al. White blood cell subtypes and neutrophil extracellular traps content as biomarkers for stroke etiology in acute ischemic stroke clots retrieved by mechanical thrombectomy. Thromb Res 2024; 234: 1-8
- 22 Sabença F, Carvalho A, Rocha M, Araújo A, Rodrigues M, Cunha A. et al. Mean platelet volume and mechanical thrombectomy. J Stroke Cerebrovasc Dis 2020; 29 (08) 104971
- 23 Abbasi M, Larco JA, Mereuta MO, Liu Y, Fitzgerald S, Dai D. et al. Diverse thrombus composition in thrombectomy stroke patients with longer time to recanalization. Thromb Res 2022; 209: 99-104
- 24 Baumann T, de Buhr N, Blume N, Gabriel MM, Ernst J, Fingerhut L. et al. Assessment of associations between neutrophil extracellular trap biomarkers in blood and thrombi in acute ischemic stroke patients. J Thromb Thrombolysis 2024; 57 (06) 936-946
- 25 Wu L, Shi P, Zhao Y, Shao D, Wu H. Hemorheology and Inflammatory Marker Changes in Patients with Acute Ischemic Stroke after Intravenous Thrombolysis with Mechanical Thrombectomy. Pak J Med Sci 2024; 40 (3Part-II): 342-346
- 26 Meseguer E, Diallo D, Labreuche J, Charles H, Delbosc S, Mangin G. et al. Osteopontin Predicts Three-Month Outcome in Stroke Patients Treated by Reperfusion Therapies. J Clin Med 2020; 9 (12) 4028
- 27 Huang JA, Wu YH, Chen PL, Weng YC, Chiang IC, Huang YT, Chou WH. MMP-9 upregulation may predict hemorrhagic transformation after endovascular thrombectomy. Front Neurol 2024; 15: 1400270
- 28 Varela R, Gonzalez-Ortiz F, Dias A, Knuth NL, Fonte J, Pinto B. et al. Plasma brain-derived tau in prognosis of large vessel occlusion ischemic stroke. Stroke 2024; 55 (09) 2353-2358
- 29 Lee TH, Cheng CN, Lee CW, Kuo CH, Tang SC, Jeng JS. Investigating sphingolipids as biomarkers for the outcomes of acute ischemic stroke patients receiving endovascular treatment. J Formos Med Assoc 2023; 122 (01) 19-28
- 30 Peng Q, Chen WEY, Deng Y, Xu Z, Wang S. et al. The Relationship Between Neuron-Specific Enolase and Clinical Outcomes in Patients Undergoing Mechanical Thrombectomy. Neuropsychiatr Dis Treat 2023; 19: 709-719
- 31 Zuo M, He Y, Chen L, Li G, Liu Q, Hou X. et al. Increased Neuron-Specific Enolase Level Predicts Symptomatic Intracranial Hemorrhage in Patients with Ischemic Stroke Treated with Endovascular Treatment. World Neurosurg 2023; 180: e302-e308
- 32 Derya O, Onur UK, Miray E, Elif SB, Ilker O, Akkan A, Zulfikar A. Fibrinogen to albumin ratio's prognostic value in ischemic stroke patients who underwent mechanical thrombectomy. Ideggyogy Sz 2024; 77 (5-6): 167-176
- 33 Wang Z, Li B, Wang Y, Maimaitili A, Qin H, Dangmurenjiafu G, Wang S. The association between serum adiponectin and 3-month outcome after ischemic stroke. Cardiovasc Diabetol 2019; 18 (01) 105
- 34 Li BH, Wang LR, Huang J, Yang S, Huang B, Jia LJ. et al. Predictive role of neutrophil-to-platelet ratio in futile recanalization of patients after endovascular therapy. Biomarkers Med 2024; 18 (04) 137-143
- 35 Zhao Y, Ning Y, Lei L, Liu Q, Li M, Lei X. et al. The relationship between atrial cardiopathy biomarkers and prognosis of patients with acute ischemic stroke after endovascular treatment. Neurotherapeutics 2024; 21 (02) e00327 Erratum in: Neurotherapeutics 2024;21(4):e00361 10.1016/j.neurot.2024.e00361
- 36 Schmalstieg-Bahr K, Gladstone DJ, Hummers E, Suerbaum J, Healey JS, Zapf A. et al. Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial. Eur J Gen Pract 2024; 30 (01) 2327367
- 37 Alcolea D, Beeri MS, Rojas JC, Gardner RC, Lleó A. Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist. Neurology 2023; 101 (04) 172-180
- 38 Hansson O, Edelmayer RM, Boxer AL, Carrillo MC, Mielke MM, Rabinovici GS. et al. The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease. Alzheimers Dement 2022; 18 (12) 2669-2686
- 39 Sharma VK, Singh TG, Mehta V, Mannan A. Biomarkers: Role and Scope in Neurological Disorders. Neurochem Res 2023; 48 (07) 2029-2058
